绘制1'-,2'-和4'-核酸修饰对呼吸道同胞性病毒RNA-依赖RNA聚合酶的影响
Priscila Sutto-Ortiz1, Barbara Selisko1, François Ferron2
1Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France.
Antiviral research
|October 13, 2025
概括
新的核酸类似物破坏了呼吸道合成病毒 (RSV) 的RNA合成. 修改后的cytidine类似物通过作为链条终结者表现出强烈的抗病毒活性,提供了一个有前途的新治疗途径.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 人类呼吸道同胞性病毒 (RSV) 导致儿童和老年人严重的呼吸道疾病.
- 现有的疫苗和抗体疗法凸显了对新型抗病毒药物的需求.
- 开发有效的抗RSV抗病毒药物仍然是关键的公共卫生优先事项.
研究的目的:
- 设计和评估具有核糖修饰的新型核酸类比物 (NA) 对其抗RSV的抗病毒潜力.
- 研究这些NAs抑制RSVRNA合成的机制.
- 为了确定赋予强大的抗病毒活性的特定修改.
主要方法:
- 合成具有各种核糖酶修饰的核酸类比物.
- 生物化学分析测量RSV聚合酶的NA纳入.
- 结构建模以了解NA-聚合酶相互作用.
- 基于细胞的测试来评估RSV复制的抑制.
- 整合效率和竞争性分析以确定聚合酶歧视.
主要成果:
- 具有4'-修饰的NAs作为有效的链终结器,破坏RNA合成延长.
- 单独的2'-F修饰没有显示链终结,而1'-修饰减缓了RNA合成.
- 丁类同类物表现出最强的抗病毒活性,与高效的酸化和整合有关.
- 由于与其他RNA病毒相比,RSV聚合酶因活性位点结构差异而包含4'-改性NAs.
结论:
- 核酸基 ribose-modified 核酸相似物,特别是那些具有4'-修饰的核酸相似物,是RSV RNA合成的强有力的抑制剂.
- 该机制涉及通过特定修改调解的链终结,其中的cytidine类似物显示出更高的疗效.
- 这些发现为开发针对RSV复制的新抗病毒疗法提供了基础.
更多相关视频
相关概念视频
Bacterial RNA Polymerase
32.5K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.5K
Bacterial RNA Polymerase
11.6K
11.6K
Eukaryotic RNA Polymerases
26.7K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
26.7K
Eukaryotic RNA Polymerases
9.1K
9.1K
RNA Editing
9.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K
Transcription Initiation
20.3K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
20.3K


